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Abstract 
Carcinosarcoma of the esophagus is a malignant neoplasm involving both 
carcinomatous and sarcomatous components. We report a patient with true esophageal 
carcinosarcoma who underwent laparoscopy-assisted surgery. An upper gastrointestinal 
barium study revealed a lobulated intraluminal filling defect in the lower intrathoracic 
esophagus. The patient underwent esophagectomy and regional lymphadenectomy with 
gastric tube reconstruction by laparoscopy-assisted surgery and thoracotomy. The 
esophageal hiatus was entered and the mediastinal esophagus was dissected using a 
laparoscopic approach. Microscopically, the tumor comprised poorly differentiated 
squamous cell carcinoma and spindle-shaped cells resembling leiomyosarcoma. 
Immunohistochemically, spindle-shaped sarcomatous cells displayed strongly positive 
reaction to vimentin and negative reaction to cytokeratin AE1/AE3 and CD68. No 
transitional zone was seen between sarcomatous and carcinomatous elements. The 
patient was finally diagnosed with true esophageal carcinosarcoma. Laparoscopic 
transhiatal esophagectomy seems to be a rational and safe procedure for lower 
esophageal neoplasms, even for patients with impaired respiratory function. 
 
Introduction 
Carcinosarcoma of the esophagus is a very rare malignant neoplasm comprising both 
carcinomatous and sarcomatous components. The oncogenesis of carcinosarcoma 
remains unclear. To date, a metaplastic concept and a collision concept have been  
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proposed. The former involves individual elements derived from a single common 
ancestor cell (so-called carcinosarcoma), while the latter involves two individual stem 
cells independently and simultaneously undergoing malignant transformation (true 
carcinosarcoma). According to a literature search using PubMed for 1981–2007, most 
reports detailed so-called carcinosarcoma, while reports of true carcinosarcoma were very 
rare. Partial or total esophagectomy with regional lymph node dissection was usually 
performed for esophageal carcinosarcoma [1–3]. Among 87 cases of carcinosarcoma 
described in the literature, 83 patients (95.4%) underwent surgical resection, 3 patients 
(3.4%) underwent local excision and 1 patient underwent endoscopic resection. 
Involvement of regional lymph nodes was seen in 31 of 59 patients (52.5%) [1]. In terms 
of prognosis, 5-year survival rates following treatment appear to be similar to those 
reported for squamous cell carcinomas [1, 2]. Although 3-year survival is higher for 
carcinosarcoma (62.8%) than for squamous cell carcinoma (28.1%), no significant 
difference in 5-year survival is apparent between the groups (26.7 vs. 22.4%). Prognosis is 
thus not as favorable as previously believed due to the high possibility of hematogenous 
metastasis in the late period [2]. Sanada et al. [4] reported that liver metastasis and 
peritoneal dissemination typically accompany sarcomatous components. 
We report herein a case of true esophageal carcinosarcoma and discuss the 
characteristics of this disease with reference to the literature. 
Case Report 
A 79-year-old man was admitted to our hospital with complaints of dysphagia. He had undergone 
percutaneous transluminal coronary angioplasty for coronary atherosclerosis 2 years earlier. Upper 
gastrointestinal studies and gastrointestinal fiberscopy revealed a lobulated intraluminal filling defect 
6.5 cm long in the lower intrathoracic esophagus (fig. 1). The tumor surface was relatively smooth and 
esophageal compliance was maintained. Enhanced computed tomography showed a tumor in the lower 
intrathoracic esophagus (fig. 2), but no metastatic lesions including lymph node metastases were 
observed. Emphysematous changes and old tuberculosis were observed in both lungs. Endoscopic 
examination showed a polypoid, lobulated lesion in the lower intrathoracic esophagus. A biopsy 
specimen showed a tumor comprising squamous cell carcinoma with spindle cell components. 
Respiratory function testing showed that vital capacity was 4,090 ml, but forced expiratory volume in 1 s 
was 49.3%, indicating an obstructive ventilatory defect. Tumor markers were within normal limits, as 
follows: carcinoembryonic antigen, 2.7 ng/ml; squamous cell carcinoma-related antigen, 1.4 ng/ml. 
Surgery was performed after obtaining informed consent. After preparation of isolated pulmonary 
ventilation during thoracic surgery, the patient was placed in the left half side lying position, and 
5 trocars were introduced, including 1 trocar for laparoscopy via the navel. After exploration of the 
peritoneal cavity, the greater curvature was mobilized by dissecting the greater omentum from the 
transverse colon using Ligasure and Autosonix. The left gastric vessels were ligated at their origin, 
allowing en bloc lymphadenectomy. Mobilization of the greater curvature was continued from distal to 
proximal while the right gastric and gastroepiploic arteries were preserved. Both crura of the diaphragm 
were incised for loose passage of the gastric tube. The esophageal hiatus was entered and the esophagus 
was dissected cranially by laparoscopic surgery. After confirming that the gastric tube could be easily 
raised to the thoracic cavity once abdominal procedures were finished, esophagectomy and mediastinal 
dissection with lymph node dissection were performed through a right thoracotomy under isolated 
pulmonary ventilation at the fifth intercostal thoracotomy. Esophagogastric anastomosis was performed 
mechanically above the level of the azygos vein, using a circular stapling device with a 2-cm free margin. 
Macroscopically, the resected tumor from the lower intrathoracic esophagus manifested as a 
lobulated polypoid lesion with a broad base and submucosal thickening of the esophageal wall. 
Histopathologically (fig. 3), the tumor showed permeation into the submucosal layer and consisted of 
poorly differentiated squamous cell carcinoma and a spindle cell sarcoma component (fig. 3a, b). 
Sarcomatous cells were arranged in broad, polygonal fascicles and displayed bizarre nuclei with 
abundant mitoses. Immunohistochemically, sarcoma components displayed strong positive results for 
vimentin, but negative results for cytokeratin AE1/AE3 (fig. 3c, d). Conversely the squamous cell 
carcinoma component showed positive results for cytokeratin, but not for vimentin. CD68 staining was  
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negative. Ki-67 (MIB-1) labeling index was high (≥25%) in both components (fig. 3e). No transitional 
zone was seen between these components (fig. 3a–d). The tumor was finally defined as esophageal true 
carcinosarcoma. No evidence of metastasis was seen in the adjacent lymph nodes. It was finally 
diagnosed as an esophageal true carcinosarcoma. 
The patient was discharged after an uneventful postoperative course and is now doing well as an 
outpatient at 9 months follow-up. 
Discussion 
Esophageal carcinosarcoma has recently been reported to account for only 0.5–2.4% of 
all esophageal tumors [2, 5] and has been classified as: (1) so-called carcinosarcoma; 
(2) pseudosarcoma; (3) true carcinosarcoma [6]. Most reported cases have involved 
so-called carcinosarcoma containing a transitional zone of carcinomatous and 
sarcomatous components. Immunohistochemical staining seems necessary to distinguish 
these lesions from true carcinosarcoma. 
In this case, squamous cell components were positive for cytokeratin AE1/AE3. In 
contrast, spindle-shaped tumor cells were positive for vimentin, a marker of 
mesenchymal components. No transitional zone was seen, and the patient was finally 
diagnosed with true carcinosarcoma. 
Some hypotheses have been nominated for the outbreak of carcinosarcoma, including: 
(1) stem cell origin theory, with tumor stem cells differentiating toward epithelial 
neoplasm and mesenchymal metaplasia; (2) tumor collision theory, with neoplasm 
derived from the collision of two distinct neoplasms, epithelial and mesenchymal in 
origin; (3) epithelial tumor theory, with a mesenchymal component that is nonneoplastic 
in origin, instead representing a reactive process to the presence of the epithelial 
neoplasm [7]. 
Oncogenesis is not completely elucidated, but some immunohistological reports using 
an electron microscope have indicated point mutation in a p53 gene. Iwaya et al. [3] 
reported that only sarcomatous cells were positive for p53, while Ohtaka et al. [8] 
reported both components as positive for p53. Histological features in the carcinomatous 
component have variously been described as squamous cell carcinoma or 
adenocarcinoma [8]. Conversely, sarcomatous components have also been reported as 
leiomyosarcoma, rhabdomyosarcoma, osteosarcoma [3, 9] or chondrosarcoma [9, 10]. 
Osamura et al. [11] reported the common origin of carcinomatous and sarcomatous 
components of these mixed tumors, noting that mesenchymal metaplasia of squamous 
cells, the nonreactive nature of sarcoma-like cells and the metastatic potential of these 
cells strongly support the theory that carcinosarcoma and pseudosarcoma represent a 
single pathological entity. Iascone and Barreca [1] reviewed 127 carcinosarcomas and 56 
pseudosarcomas, showing that these neoplasms display similar clinical and behavioral 
outcomes. 
More than 80% of carcinosarcomas are located in the middle and/or lower esophagus 
[2]. Macroscopically, carcinosarcomas were 75% polypoid type and 15% ulcerative type 
[2]. When sarcomatous components are predominant, macroscopic type is polypoid 
because of the few stromal ingredients. Likewise, when carcinomatous components are 
predominant, ulcerative type is usual.  
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Tumor invasion was limited to the esophageal wall in 80% of carcinosarcomas and 
40.6% of squamous cell carcinomas. Depth of invasion was limited to the esophageal wall 
more often in the carcinosarcoma group than in the squamous cell carcinoma group [2]. 
Partial or total esophagectomy with regional lymph node dissection was usually 
performed for carcinosarcoma of the esophagus [1–3]. Among 87 carcinosarcoma 
patients, 83 patients (95.4%) underwent surgical resection, 3 patients (3.4%) underwent 
local excision and 1 patient underwent endoscopic resection. Involvement of regional 
lymph nodes was seen in 31 of 59 patients (52.5%) with carcinosarcoma [1]. 
McCort [12] concluded in his review that carcinosarcoma has a more favorable 
prognosis compared to squamous cell carcinoma. Xu et al. [13] reported that the 
carcinomatous component of the tumor is usually at an early stage at the time of 
diagnosis and the incidence of lymph node metastasis is thus low. However, 5-year 
survival rates following treatment resemble those reported for squamous cell carcinomas 
[1, 2]. At 5 years after surgery, only 9 of 55 patients (16.4%) were reported alive and free 
from disease or dead of unrelated causes [1]. Iyomasa et al. [2] compared 20 cases of 
carcinosarcoma with 773 cases of squamous cell carcinoma. Although the 3-year survival 
rate was higher for carcinosarcoma (62.8%) than for squamous cell carcinoma (28.1%), no 
significant difference in 5-year survival is apparent between the two groups (26.7 vs. 
22.4%). The prognosis is not as favorable as previously believed, due to the high 
possibility of hematogenous metastasis in the late period. Sanada et al. [4] have reported 
that liver metastasis and peritoneal dissemination typically accompany sarcomatous 
components. 
There were few reports of radiotherapy and chemotherapy. Iwaya et al. [3] reported 
that radiotherapy could not control tumor growth. Sanada et al. [4] reported that 
chemotherapy (docetaxel + 5FU) and radiotherapy (66 Gy) for 2 months achieved a 
reduction rate of 45% for the primary lesion. 
Our patient underwent laparoscopy-assisted gastrectomy which contributed to 
dissection of the lower thoracic esophagus via the esophageal hiatus and which led to 
shortened duration of thoracic procedures under isolated ventilation. The postoperative 
course was uneventful and he is now doing well without recurrence. We encountered an 
extremely rare case of true esophageal carcinosarcoma. 
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Fig. 1. Upper gastrointestinal barium study and gastrointestinal fiberscopy revealed a lobulated 
intraluminal filling defect of 6.5 cm in the lower intrathoracic esophagus. 
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Fig. 2. Enhanced computed tomography showing tumor in the lower intrathoracic esophagus. 
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Fig. 3. Histopathological findings for tumor. a Hematoxylin and eosin (HE) ×10. b HE ×20. 
c Cytokeratin AE1/AE3 stain. d Vimentin stain. e Ki-67 stain. 
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